<乌鸦传媒>Adjuvant Anti-PD-1 Misses on OS in High-Risk Melanoma But pembrolizumab topped active controls for relapse-free survival Jun 07, 2021
<乌鸦传媒>Lymph Node Findings on PET: Cancer or COVID Vaccine? Post-jab radiotracer uptake "could prompt unnecessary biopsies and treatments" May 26, 2021
<乌鸦传媒>Bad Day Sunshine: Benzene Found in Many Sun Care Products Valisure also detected the carcinogen in hand sanitizers earlier this year May 26, 2021
<乌鸦传媒>Methotrexate Impairs COVID Vax Response Can extra vaccine doses or discontinuing drug benefit patients with immune-mediated diseases? May 25, 2021
<乌鸦传媒>Unhealthy Quest for Lighter Skin Fuels Bleaching Epidemic Breaking the centuries-old cycle of myths about skin color May 25, 2021
<乌鸦传媒>Plaque Psoriasis Drug Shows Promise for Psoriatic Arthritis Monoclonal antibody targets the IL-23 p19 subunit May 20, 2021
<乌鸦传媒>Novel Immunotherapy Boosts Melanoma Outcomes Adding LAG-3 checkpoint inhibitor to nivolumab extended PFS in patients with advanced disease May 19, 2021
<乌鸦传媒>For Safety, One Biologic a Winner in Psoriasis, Psoriatic Arthritis Lower hospitalization rates compared with other biologics or small molecule therapies May 19, 2021
<乌鸦传媒>Rituximab Tops Mycophenolate Mofetil for Pemphigus Vulgaris Sustained complete response rate four times higher with anti-CD20 antibody May 19, 2021
<乌鸦传媒>Is This the Most TikTok'd COVID Vaccine Side Effect? Dermatologists say there's no issue: 'Happy filling, happy vaccinating' May 12, 2021
<乌鸦传媒>No Clarity for Role of Laser Therapy in Vulvar Lichen Sclerosus Mixed results from two small randomized clinical trials May 10, 2021
<乌鸦传媒>Doubling Down on Immunotherapy in Advanced Melanoma Checkpoint inhibitor combo active after upfront anti-PD-1/L1 therapy May 09, 2021
<乌鸦传媒>Another COVID-19 Side Effect: 'Zoom Dysmorphia' As people spend more time on camera, many of them like themselves less and less May 06, 2021
<乌鸦传媒>First Detailed Look at COVID Vaccine Skin Reactions Mostly mild, self-limiting reactions and no serious adverse reactions May 05, 2021
<乌鸦传媒>Rapid Improvement in Atopic Dermatitis With New JAK1 Inhibitor Plus: First-in-class drug shows promise in AD, BTK inhibitor active in pemphigus May 03, 2021
<乌鸦传媒>Topical JAK Inhibitor Shows Promise in Vitiligo Half of patients had 90% improvement after 2 years of treatment Apr 30, 2021
<乌鸦传媒>High Rate of Hyperhidrosis Relief With Topical Agent Benefit for 86% of patients treated with sofpironium bromide Apr 29, 2021
<乌鸦传媒>Rapid Improvement in Atopic Dermatitis With Topical JAK Inhibitor Disease activity index improved as early as week 1 with delgocitinib cream Apr 27, 2021
<乌鸦传媒>Significant Improvement in Hand Eczema With Pan-JAK Inhibitor Disease activity indicators reduced, no safety signals with gusacitinib versus placebo Apr 26, 2021
<乌鸦传媒>Drug 'TYKs' All the Boxes in Two Plaque Psoriasis Trials Significantly higher response rates with TYK2 inhibitor deucravacitinib versus apremilast Apr 25, 2021
<乌鸦传媒>Big Win in Psoriasis for Dual IL-17A/17F Inhibitor Significant differences in clearance with bimekizumab vs secukinumab at all time points Apr 23, 2021
<乌鸦传媒>Op-Ed: Dermatology Needs Lower Costs and Better Care A proposal for value-based care Apr 21, 2021
<乌鸦传媒>Nivolumab Alone Prevails in Resected Melanoma Adding ipilimumab in adjuvant setting failed to improve relapse-free survival Apr 11, 2021
<乌鸦传媒>For Enthesitis in Psoriatic Arthritis, Target IL-23 Targeted agent provides relief for many PsA patients Apr 08, 2021
<乌鸦传媒>COVID Triggers Novel Infectious Skin Condition in Teen Mild case led to unusual effects a week later Apr 07, 2021
<乌鸦传媒>JAK Inhibitor Promising in Psoriatic Arthritis Oral agent noninferior to adalimumab in joint symptoms Apr 01, 2021
<乌鸦传媒>A Win for Adjuvant Immunotherapy in Esophageal Cancer And other highlights from the Society of Surgical Oncology's virtual 2021 meeting Mar 31, 2021
<乌鸦传媒>Don't Stop Taltz in Psoriatic Arthritis Significantly more patients relapsed, and more quickly, after withdrawal Mar 10, 2021
<乌鸦传媒>Using the Skin Microbiome to Control Atopic Dermatitis Bacteria-based therapy shows promise in proof-of-concept trial Mar 01, 2021
<乌鸦传媒>Young Hidradenitis Suppurativa Patients See Lags in Care Diagnosis typically came years after disease onset; providers claim lack of knowledge on HS pain Feb 24, 2021
<乌鸦传媒>Want Data on Recently Approved Actinic Keratosis Drug? Here You Go Phase III trial now published in full for topical anti-proliferative treatment Feb 10, 2021
<乌鸦传媒>First Immunotherapy Approved for Basal Cell Carcinoma Objective responses in 27% of previously treated patients who received cemiplimab Feb 10, 2021
<乌鸦传媒>Monoclonal Antibody Highly Effective in Phase III Psoriasis Trial Beats ustekinumab, but main side effect was oral candidiasis Feb 05, 2021
<乌鸦传媒>Brain Tumor Risk Upped With Synthetic Progestogen Absolute risk still low, however, and product not currently approved in U.S. Feb 03, 2021
<乌鸦传媒>High Potassium No Threat With Spironolactone Despite guidelines, many still monitoring K levels in young women with acne, researchers find Jan 27, 2021
<乌鸦传媒>Masculinizing Hormone Therapy Tied to Acne in Transmen Acne also linked with depression and anxiety; Accutane may be treatment option Jan 20, 2021
<乌鸦传媒>Op-Ed: Gym for Surgeons? To perform like athletes, surgeons need to train like athletes Dec 26, 2020
<乌鸦传媒>Derm Symptoms Signal MIS-C in Kids Case series shows mucocutaneous findings in most children Dec 09, 2020
<乌鸦传媒>Renewed Concerns About Finasteride and Mental Health Database study links popular alopecia treatment with increased risks of suicidality, depression Nov 27, 2020
